LetterPhase II study of oral miltefosine in patients with squamous cell head and neck cancer
References (4)
- et al.
Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)
Eur J Cancer Clin Oncol
(1988) - et al.
Hexadecylphosphocholine: a new and selective antitumor drug
Cancer Treat Rev
(1990)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 1993 Published by Elsevier Ltd.